Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 4,575.00
-120.00 (-2.56%)
Jun 10, 2026, 3:30 PM KST
Bio Plus Market Cap
Bio Plus has a market cap or net worth of 281.55 billion as of June 10, 2026. Its market cap has decreased by -40.52% in one year.
Market Cap
281.55B
Enterprise Value
336.32B
Revenue
94.42B
Ranking
n/a
PE Ratio
34.28
Stock Price
4,575.00
Market Cap Chart
Since September 27, 2021, Bio Plus's market cap has decreased from 451.40B to 281.55B, a decrease of -37.63%. That is a compound annual growth rate of -9.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 288.93B | -6.66% |
| Dec 30, 2025 | 309.55B | -24.79% |
| Dec 30, 2024 | 411.57B | 4.76% |
| Dec 28, 2023 | 392.88B | -2.28% |
| Dec 29, 2022 | 402.04B | 1.78% |
| Dec 30, 2021 | 395.00B | -12.50% |
| Sep 27, 2021 | 451.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SEERS | 1.07T |
| WON TECH | 646.77B |
| InBody Co.,Ltd | 608.89B |
| i-SENS | 485.41B |
| Curexo | 416.31B |
| ToolGen | 396.24B |
| DRTECH | 109.35B |
| T&R Biofab | 96.28B |